InsiderClue
Insiders · Profile

Henderson Jane

Chief Financial Officer at Apogee Therapeutics · Sr. V.P. & CFO, Corp. Dev. at Voyager Therapeutics. Filing since 16 Mar 2018. CIK 0001422304

APGE Apogee Therapeutics, Inc. Chief Financial Officer · 14 trades VYGR Voyager Therapeutics, Inc. Sr. V.P. & CFO, Corp. Dev. · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
APGE Apogee Therapeutics, Inc.
1 May 2026
Chief Financial Officer
Sold on a plan
2,000
$164.08K
1.1%
APGE Apogee Therapeutics, Inc.
16 Apr 2026
Chief Financial Officer
Sold on a plan
2,000
$180.00K
1.1%
APGE Apogee Therapeutics, Inc.
1 Apr 2026
Chief Financial Officer
Sold on a plan
2,000
$170.02K
1.1%
APGE Apogee Therapeutics, Inc.
25 Mar 2026
Chief Financial Officer
Sold on a plan
2,000
$170.00K
1.1%
APGE Apogee Therapeutics, Inc.
2 Mar 2026
Chief Financial Officer
Sold on a plan
2,000
$140.43K
1.1%
APGE Apogee Therapeutics, Inc.
2 Feb 2026
Chief Financial Officer
Sold on a plan
2,000
$131.63K
1.1%
APGE Apogee Therapeutics, Inc.
6 Jan 2026
Chief Financial Officer
Sold on a plan
2,000
$160.00K
1.1%
APGE Apogee Therapeutics, Inc.
2 Jan 2026
Chief Financial Officer
Sold on a plan
6,000
$449.15K
3.1%
APGE Apogee Therapeutics, Inc.
19 Dec 2025
Chief Financial Officer
Sold on a plan
1,500
$120.00K
0.8%
APGE Apogee Therapeutics, Inc.
4 Dec 2025
Chief Financial Officer
Sold on a plan
1,500
$112.50K
0.8%
APGE Apogee Therapeutics, Inc.
25 Nov 2025
Chief Financial Officer
Sold on a plan
1,500
$105.00K
0.8%
APGE Apogee Therapeutics, Inc.
14 Nov 2025
Chief Financial Officer
Sold on a plan
2,000
$130.00K
1.0%
APGE Apogee Therapeutics, Inc.
11 Nov 2025
Chief Financial Officer
Sold on a plan
1,000
$60.00K
0.5%
APGE Apogee Therapeutics, Inc.
23 Aug 2024
Chief Financial Officer
Sold at will
6,000
$289.56K
2.9%
VYGR Voyager Therapeutics, Inc.
23 Mar 2018
Sr. V.P. & CFO, Corp. Dev.
Sold, plan not stated
11,200
$229.82K
100%
VYGR Voyager Therapeutics, Inc.
22 Mar 2018
Sr. V.P. & CFO, Corp. Dev.
Sold, plan not stated
19,900
$419.29K
100%
VYGR Voyager Therapeutics, Inc.
19 Mar 2018
CFO & SVP, Corp. Dev.
Sold, plan not stated
1,900
$41.34K
100%
VYGR Voyager Therapeutics, Inc.
16 Mar 2018
CFO & SVP, Corp. Dev.
Sold, plan not stated
15,416
$341.46K
100%
18 decisions on file.